AlphaYou
Overview
Smart money at a glance
Filings to Sep 27, 2026Net selling: insiders sold $1.4M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$1.4M netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 1 added, 0 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Sep 27- Open
- $56.14
- 52-wk high
- $78.48
- High
- $56.39
- 52-wk low
- $44.12
- Low
- $53.92
- Prev close
- $55.70
- Mkt cap
- $5.24B
- Volume
- 1.01M
- Fwd P/E
- 23.4x
- Beta
- 1.76
- P/S
- 391.6x
- P/B
- 3.1x
- Profit margin
- +0.0%
- Op margin
- -1128.0%
- ROE
- -26.1%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about CRSP filings
Are insiders buying or selling Crispr Therapeutics AG (CRSP) stock?
Net selling: insiders sold $1.4M and bought $0 of CRSP stock on the open market in the 90 days to Sep 27, 2026, according to SEC Form 4 filings. $626K of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Behbahani, Ali (Director), who sold $781K. The latest filing was on Sep 24, 2026.
Which members of Congress have traded CRSP recently?
None. No member of Congress disclosed a CRSP trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this CRSP smart-money data?
This summary uses filings available on Sep 27, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (2)
- DS
D.E. Shaw
$48.7M
bought
- SU
Susquehanna
$28.2M
bought
Sells/Trims (1)
- SQ
Squarepoint
$23.2M
trimmed
What insiders are doing
How top traders are positioned
No tracked top-trader positions in CRSP right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 14.5% above what analysts expected.
Earnings per share
-$1.10 expected
Reports Nov 9, 2026, in 43 days
Estimates as of Sep 27, 2026
EPS expected
-$1.50 to -$0.46
Revenue expected
15 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
Financials
Is the business strong?
This company is running thin margins.
- Net margin
- 0.0%
- Forward P/E
- 23.36
- Market cap
- $5.2B
Valuation
- P/S391.55
- P/B3.09
Quality
- Operating margin-1128.0%
- ROE-26.1%
- ROA-14.2%
Growth
- Beta1.76
Technicals
Price structure
This stock is trending upward.
Trend
Constructive
60 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace